Search for
Advanced Full Body
Full Body
68 parameters
Report in 24Hrs
At Home
Fasting Required
Details
Advanced Health covering Blood, Diabetes, Heart, Liver, Kidney, Thyroid, Iron, Sugar, Inflamation, Bone & Vitamins
₹1,289₹1,999
36% OFF
Parameters
- List of Tests
- Sugar (Glucose) Random
- CBC - Complete Hemogram
- Liver Function Test
- Albumin
- Alkaline Phosphatase
- Bilirubin - Direct
- Bilirubin - Indirect
- Bilirubin - Total
- AST/SGOT
- ALT/SGPT
- Total Protein
- A/G Ratio
- Gamma GT
- Globulin
- Kidney Profile
- BUN
- Calcium
- Creatinine
- Uric Acid
- eGFR
- BUN/Creatinine
- Urea
- Lipid Profile
- Cholestrol/HDL
- LDL/HDL
- Non HDL
- VLDL
- Total Cholestrol
- Triglycerides
- HDL
- LDL
- Iron Studies
- Iron
- TIBC
- Transferrin Saturation
- Thyroid Profile
- Total T3
- Total T4
- TSH
- Hba1c
- eAG
- ESR
- Calcium
- Vitamin B12
- 25 OH Vitamin D
Advanced Wellness Package
- Why is it done?
- Comprehensive health screening to assess overall metabolic, endocrine, and systemic organ function for preventive healthcare and early disease detection
- Screening for metabolic disorders including diabetes, thyroid dysfunction, and cardiovascular disease risk
- Evaluation of liver and kidney function to detect organ dysfunction or disease
- Assessment of blood cell counts and hemoglobin levels for anemia and hematologic disorders
- Evaluation of nutritional status including iron stores, vitamin B12, and vitamin D levels
- Monitoring chronic conditions such as diabetes, hypertension, or dyslipidemia
- Routine annual physical examination baseline and risk stratification
- Detection of inflammatory markers and systemic inflammation
- Assessment of glucose control and long-term diabetes risk in asymptomatic individuals
- Synergistic evaluation allowing correlation of multiple organ systems for comprehensive health assessment
- Normal Range
- Sugar (Glucose) Random: 70-100 mg/dL (fasting) or <140 mg/dL (random); Normal indicates adequate glucose regulation
- CBC - Complete Hemogram: Hemoglobin 12.0-16.0 g/dL (female), 13.5-17.5 g/dL (male); WBC 4.5-11.0 x10³/μL; Platelets 150-400 x10³/μL; RBC 4.0-5.5 x10⁶/μL (female), 4.5-6.0 x10⁶/μL (male); Normal ranges indicate healthy blood cell populations
- Liver Function Test - Total Bilirubin: 0.1-1.2 mg/dL; Direct Bilirubin: 0.0-0.3 mg/dL; Indirect Bilirubin: 0.1-1.0 mg/dL; Normal values indicate adequate hepatic function
- Liver Function Test - AST/SGOT: 10-40 IU/L; ALT/SGPT: 7-56 IU/L; Normal indicates minimal hepatic inflammation
- Liver Function Test - Alkaline Phosphatase: 30-120 IU/L; Albumin: 3.5-5.0 g/dL; Total Protein: 6.0-8.3 g/dL; Globulin: 2.3-3.5 g/dL; A/G Ratio: 1.0-2.5; Gamma GT: 0-51 IU/L (female), 0-73 IU/L (male)
- Kidney Profile - Creatinine: 0.6-1.2 mg/dL (female), 0.7-1.3 mg/dL (male); BUN: 7-20 mg/dL; Urea: 15-45 mg/dL; Normal values indicate normal glomerular filtration rate
- Kidney Profile - eGFR: ≥60 mL/min/1.73m² (normal kidney function); BUN/Creatinine Ratio: 10-20; Calcium: 8.5-10.2 mg/dL; Uric Acid: 3.5-7.2 mg/dL (female), 3.5-7.2 mg/dL (male)
- Lipid Profile - Total Cholesterol: <200 mg/dL (desirable); HDL: >40 mg/dL (female), >50 mg/dL (male); LDL: <100 mg/dL (optimal); VLDL: <30 mg/dL; Triglycerides: <150 mg/dL; Cholesterol/HDL Ratio: <5.0; LDL/HDL Ratio: <3.0; Non-HDL: <130 mg/dL
- Iron Studies - Iron: 60-170 mcg/dL (female), 75-175 mcg/dL (male); TIBC: 250-425 mcg/dL; Transferrin Saturation: 20-50%; Normal values indicate adequate iron stores without overload
- Thyroid Profile - TSH: 0.4-4.0 mIU/L; Total T3: 80-200 ng/dL; Total T4: 4.5-12.0 mcg/dL; Normal values indicate euthyroid state
- HbA1c: <5.7% (normal glucose tolerance); eAG: <100 mg/dL equivalent (normal glucose control); Normal values indicate no diabetes or prediabetes
- ESR (Erythrocyte Sedimentation Rate): <20 mm/hr (female), <15 mm/hr (male); Normal values indicate absence of significant inflammation
- Vitamin B12: 200-900 pg/mL or 148-664 pmol/L; Normal values indicate adequate B12 stores
- 25-OH Vitamin D: 30-100 ng/mL or 75-250 nmol/L (sufficient); Normal values indicate adequate vitamin D status
- Interpretation
- Sugar (Glucose) Random - Elevated (>140 mg/dL): Suggests impaired glucose tolerance, prediabetes, or diabetes; requires fasting glucose and HbA1c confirmation. Low (<70 mg/dL): Indicates hypoglycemia requiring clinical correlation
- CBC - Hemoglobin Low: Anemia (iron deficiency, chronic disease, or hemolysis); High: Polycythemia or hemoconcentration. WBC High: Infection, leukemia, or stress; Low: Immunosuppression or bone marrow failure. Platelets Low: Thrombocytopenia increasing bleeding risk; High: Thrombocytosis or reactive process
- Liver Function - Elevated Bilirubin: Indicates jaundice, hemolysis, or hepatic/biliary obstruction; direct elevation suggests hepatic damage or obstruction; indirect suggests hemolysis. Elevated AST/ALT: Indicates hepatocellular injury from viral hepatitis, cirrhosis, or fatty liver disease
- Liver Function - Elevated Alkaline Phosphatase: Indicates cholestasis, bone disease, or pregnancy; when combined with elevated GGT suggests hepatic origin. Low Albumin: Suggests liver synthetic dysfunction, malnutrition, or proteinuria. Elevated Gamma GT: Indicates hepatobiliary disease or alcohol consumption
- Kidney Profile - Elevated Creatinine: Indicates reduced GFR and renal dysfunction; staging depends on eGFR calculation. Elevated BUN: Suggests prerenal (dehydration, shock) or renal disease; BUN/Creatinine ratio helps differentiate. Elevated Uric Acid: Risk for gout and uric acid kidney stones; associated with metabolic syndrome
- Kidney Profile - Low eGFR (<60): Indicates chronic kidney disease requiring staging and monitoring. Low Calcium: May indicate vitamin D deficiency, hypoparathyroidism, or kidney disease. High Calcium: Suggests hyperparathyroidism, malignancy, or vitamin D toxicity
- Lipid Profile - Elevated Total Cholesterol/LDL: Cardiovascular disease risk, particularly if LDL >100 mg/dL; requires lifestyle modification and possible statin therapy. Low HDL: Major cardiovascular risk factor; target HDL >50 mg/dL in females, >40 mg/dL in males
- Lipid Profile - Elevated Triglycerides: Associated with VLDL elevation, increasing cardiovascular risk; often related to poor diet, obesity, or metabolic syndrome. Non-HDL >130 mg/dL indicates atherogenic particle burden. Elevated ratios suggest suboptimal lipid profile requiring intervention
- Iron Studies - Low Iron/High TIBC/Low Transferrin Saturation: Iron deficiency anemia requiring investigation for source (bleeding, malabsorption). High Iron/Low TIBC/High Saturation: Hemochromatosis risk requiring ferritin and liver imaging. Normal studies rule out iron disorders
- Thyroid Profile - Elevated TSH: Primary hypothyroidism requiring L-thyroxine replacement. Low TSH: Hyperthyroidism or over-replacement; causes palpitations and atrial fibrillation risk. Abnormal T3/T4 patterns help differentiate thyroid disorders and assess severity
- HbA1c 5.7-6.4%: Prediabetes indicating increased diabetes risk; lifestyle intervention recommended. HbA1c ≥6.5%: Diagnostic of diabetes requiring pharmacologic management and close monitoring
- ESR Elevated: Non-specific marker of inflammation suggesting infection, malignancy, autoimmune disease, or inflammation; requires clinical correlation and additional testing
- Vitamin B12 - Low (<200 pg/mL): Pernicious anemia, dietary deficiency, or malabsorption; causes neurologic symptoms if untreated. Borderline (200-300 pg/mL): May warrant supplementation depending on symptoms. Low-normal with neurologic symptoms suggests functional deficiency
- 25-OH Vitamin D - <20 ng/mL: Deficiency causing rickets or osteomalacia; 20-29 ng/mL: Insufficiency increasing osteoporosis risk; ≥30 ng/mL: Sufficient but <100 ng/mL optimal; >100 ng/mL: Risk for toxicity and hypercalcemia
- Associated Organs
- Sugar (Glucose) Random: Pancreas (beta cells) - Evaluates insulin secretion and glucose homeostasis; abnormalities indicate diabetes mellitus type 1 or 2, pancreatic insufficiency, or metabolic syndrome complications
- CBC - Complete Hemogram: Bone marrow - Evaluates hematopoiesis and circulating blood cell populations; abnormalities indicate leukemia, aplastic anemia, myelodysplasia, infection, or hemolytic processes
- Liver Function Tests: Liver and biliary system - Evaluates hepatic synthetic function, detoxification, and bile metabolism; abnormalities indicate viral hepatitis, cirrhosis, alcoholic liver disease, cholestasis, or biliary obstruction
- Kidney Profile: Kidneys and urinary system - Evaluates glomerular filtration rate, tubular function, and fluid/electrolyte balance; abnormalities indicate chronic kidney disease, acute kidney injury, nephrotic syndrome, or mineral metabolism disorders
- Lipid Profile: Cardiovascular system and liver - Evaluates atherosclerotic cardiovascular disease risk and hepatic lipid metabolism; abnormalities indicate dyslipidemia, metabolic syndrome, or increased myocardial infarction/stroke risk
- Iron Studies: Bone marrow and liver (storage) - Evaluates iron homeostasis and hematopoiesis; abnormalities indicate iron deficiency anemia, hemochromatosis, or secondary iron loading
- Thyroid Profile: Thyroid gland and pituitary - Evaluates thyroid hormone production and hypothalamic-pituitary-thyroid axis; abnormalities indicate hypothyroidism, hyperthyroidism, thyroiditis, or pituitary dysfunction
- HbA1c and eAG: Pancreas and red blood cells - Evaluates long-term glucose control and red blood cell glycation; abnormalities indicate diabetes mellitus or impaired glucose tolerance affecting multiple organ systems
- ESR: General systemic marker - Evaluates inflammatory response affecting various organs and systems; abnormalities indicate infection, malignancy, autoimmune disease, or tissue inflammation
- Calcium: Bones, parathyroid glands, and kidneys - Evaluates mineral metabolism and bone health; abnormalities indicate parathyroid disease, vitamin D disorders, bone disease, or malignancy
- Vitamin B12: Gastrointestinal tract and bone marrow - Evaluates B12 absorption and hematopoiesis; abnormalities indicate pernicious anemia, dietary deficiency, malabsorption, or neurologic complications
- 25-OH Vitamin D: Kidneys, bones, intestines, and parathyroid glands - Evaluates vitamin D status affecting calcium homeostasis and immune function; abnormalities indicate deficiency-related osteoporosis, rickets, or immune dysfunction
- Follow-up Tests
- Sugar (Glucose) Random Elevated: Recommend fasting glucose, oral glucose tolerance test (OGTT), and HbA1c; if diabetes confirmed, monitor glucose quarterly with HbA1c every 3-6 months initially
- CBC Abnormalities: Low hemoglobin warrants iron studies, peripheral smear, and reticulocyte count; elevated WBC requires differential count and blood culture if febrile; low platelets requires bone marrow biopsy if severe
- Elevated Bilirubin/Liver Enzymes: Recommend viral hepatitis panel (HAV, HBV, HCV), ultrasound abdomen for cirrhosis assessment, and autoimmune markers (ANA, anti-smooth muscle antibodies) if acute hepatitis suspected
- Elevated Liver Enzymes AST>ALT: Recommend GGT for hepatic origin confirmation, ultrasound to assess for fatty liver disease, and consider ethanol consumption history assessment
- Low Albumin with Liver Dysfunction: Recommend prothrombin time (PT/INR) to assess synthetic function, ultrasound for cirrhosis features, and consider hepatology referral if significantly reduced
- Elevated Creatinine/Low eGFR: Recommend urine analysis for proteinuria/hematuria, renal ultrasound to assess structure, and monitor renal function every 3-6 months with repeat creatinine and eGFR calculations
- Elevated BUN with Normal Creatinine: Recommend hydration assessment, repeat testing after hydration, and evaluate for gastrointestinal bleeding source
- Elevated Uric Acid: Recommend urine uric acid, assess for gout symptoms, and consider xanthine oxidase inhibitor therapy; monitor annually or after medication changes
- Abnormal Lipid Profile: Recommend repeat fasting lipid panel, consider advanced lipid testing (particle size/number), assess for familial hypercholesterolemia, and monitor every 3-6 months if on statin therapy
- Low HDL: Recommend lifestyle intervention (exercise, diet), consider niacin or fibrates as adjunctive therapy, and recheck in 3 months
- Elevated Triglycerides: Recommend fasting repeat test, assess alcohol use and carbohydrate intake, consider fibrate therapy, and recheck every 3 months initially
- Abnormal Iron Studies: If low iron, recommend colonoscopy/upper endoscopy for bleeding source, consider iron supplementation, and recheck in 2-3 months. If high, recommend genetic testing for hemochromatosis gene mutations and liver imaging
- Elevated TSH: Recommend free T4 measurement, antithyroid peroxidase (TPO) antibodies for autoimmune thyroiditis, and initiate L-thyroxine with recheck TSH in 6-8 weeks
- Low TSH: Recommend free T4 and free T3 measurement, consider thyroid ultrasound and technetium scan if thyroiditis suspected, and manage accordingly with antithyroid drugs or beta-blockers
- HbA1c 5.7-6.4% (Prediabetes): Recommend repeat HbA1c, lifestyle intervention (weight loss, exercise, diet modification), and recheck annually; consider metformin therapy if additional risk factors present
- HbA1c ≥6.5% (Diabetes): Recommend diabetic complications screening (urine albumin-creatinine ratio, dilated eye exam, foot exam), ECG if cardiac risk factors, and initiate pharmacologic therapy with monitoring HbA1c every 3-6 months
- Elevated ESR: Recommend blood cultures if fever, chest X-ray, ECG, and tissue biopsy if malignancy suspected; consider repeat ESR in 2-4 weeks to assess trend
- Abnormal Calcium: If low, recommend serum albumin-corrected calcium, phosphate, magnesium, PTH, and 25-OH vitamin D; consider parathyroid imaging if PTH elevated. If high, recommend PTH, 25-OH vitamin D, and imaging if PTH suppressed
- Low Vitamin B12: Recommend intrinsic factor antibodies and parietal cell antibodies to diagnose pernicious anemia; methylmalonic acid and homocysteine if neurologic symptoms present; initiate B12 replacement with intramuscular injections
- Vitamin D Deficiency (<20 ng/mL): Recommend ergocalciferol or cholecalciferol supplementation, dietary calcium assessment, and recheck 25-OH vitamin D in 2-3 months. For insufficiency (20-29 ng/mL), recommend cholecalciferol supplementation and recheck in 2-3 months
- Overall Package Monitoring: For abnormal results, recommend repeat comprehensive testing in 3-6 months after initiating interventions; for multiple abnormalities suggesting metabolic syndrome, recommend formal diagnosis assessment and cardiology referral
- Fasting Required?
- YES - Fasting required for 8-12 hours prior to blood draw for optimal test accuracy
- Tests specifically requiring fasting: Sugar (Glucose) Random for most accurate interpretation, Lipid Profile (total cholesterol, LDL, HDL, triglycerides significantly affected by food intake), Kidney Profile (urea and creatinine may be elevated non-fasting)
- Tests not significantly affected by fasting: CBC, Liver Function Tests, Thyroid Profile, Iron Studies, HbA1c, ESR, Vitamin B12, 25-OH Vitamin D can be performed non-fasting but fasting ensures consistency
- Medication guidelines: Continue all regular medications unless specifically instructed otherwise by healthcare provider; certain medications (statins, diabetes medications, thyroid medications) should be taken as scheduled
- Avoid medications that may interfere: NSAIDs, certain antibiotics, and excess vitamin supplementation should be discussed with healthcare provider as timing may affect results
- Dietary restrictions: No food intake for 8-12 hours before testing; water intake is allowed and encouraged; avoid alcohol for 24 hours prior to testing as it affects lipid and liver function results
- Timing recommendations: Schedule blood draw between 7-9 AM for optimal accuracy; consistent timing helps with serial test comparisons
- Activity restrictions: Avoid strenuous exercise for 24 hours before testing as physical activity affects glucose, enzyme, and lipid levels
- Stress management: Avoid emotional stress if possible as stress hormones affect glucose and other metabolic parameters
- Sample collection: Venous blood sample collected in appropriate tubes (SST for serum chemistry, EDTA for hematology); proper labeling and chain of custody maintained for test accuracy
- Special considerations: Women should be aware that certain results (iron levels, calcium) may vary with menstrual cycle; postmenopausal status affects some parameters; inform phlebotomist of current pregnancy or lactation
How our test process works!

